CT analysis of the effect of pirfenidone in patients with idiopathic pulmonary fibrosis

European Journal of Radiology

Volumn 83, Issue 1, 2014, Pages 32-38

  Iwasawa, Tae ^a   Ogura, Takashi ^a   Sakai, Fumikazu ^b   Kanauchi, Tetsu ^c   Komagata, Takanobu ^a   Baba, Tomohisa ^a   Gotoh, Toshiyuki ^d   Morita, Satoshi ^e   Yazawa, Takuya ^f   Inoue, Tomio ^g  

^a Kanagawa Prefectural Cardiovascular and Respiratory Center Hospital   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

^c Saitama Cardiovascular and Respiratory Center ^*  (Japan)

^d YOKOHAMA NATIONAL UNIVERSITY   (Japan)

^e YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^f KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Computed tomography; Idiopathic pulmonary fibrosis; Lung; Lung disease; Pirfenidone

Indexed keywords

PIRFENIDONE;

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG EFFECT; DRUG RESPONSE; FEMALE; FIBROSING ALVEOLITIS; HUMAN; IMAGE ANALYSIS; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; RADIOLOGIST; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; VITAL CAPACITY;

COMPUTED TOMOGRAPHY; IDIOPATHIC PULMONARY FIBROSIS; LUNG; LUNG DISEASE; PIRFENIDONE;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LUNG; MALE; PYRIDONES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84892371487     PISSN: 0720048X     EISSN: 18727727     Source Type: Journal    
DOI: 10.1016/j.ejrad.2012.02.014     Document Type: Article

References (20)

1. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001 Am J Respir Crit Care Med 165 2 2002 277 304
2. S.N. Iyer, G. Gurujeyalakshmi, and S.N. Giri Effects of pirfenidone on transforming growth factor-beta gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis J Pharmacol Exp Ther 291 1 1999 367 373
3. G. Gurujeyalakshmi, M.A. Hollinger, and S.N. Giri Pirfenidone inhibits PDGF isoforms in bleomycin hamster model of lung fibrosis at the translational level Am J Physiol 276 2 Pt 1 1999 L311 L318
4. H. Oku, T. Shimizu, and T. Kawabata et al. Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis Eur J Pharmacol 590 1-3 2008 400 408
5. T. Kakugawa, H. Mukae, and T. Hayashi et al. Pirfenidone attenuates expression of HSP47 in murine bleomycin-induced pulmonary fibrosis Eur Respir J 24 1 2004 57 65
6. H. Taniguchi, M. Ebina, and Y. Kondoh et al. Pirfenidone in idiopathic pulmonary fibrosis Eur Respir J 35 4 2010 821 829
7. A. Azuma, T. Nukiwa, and E. Tsuboi et al. Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis Am J Respir Crit Care Med 171 9 2005 1040 1047
8. D.A. Lynch, J.D. Godwin, and S. Safrin et al. High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis Am J Respir Crit Care Med 172 4 2005 488 493
9. A.C. Best, J. Meng, and A.M. Lynch et al. Idiopathic pulmonary fibrosis: physiologic tests, quantitative CT indexes, and CT visual scores as predictors of mortality Radiology 246 3 2008 935 940
10. M. Akira, M. Sakatani, and E. Ueda Idiopathic pulmonary fibrosis: progression of honeycombing at thin-section CT Radiology 189 3 1993 687 691
11. H. Arakawa, K. Fujimoto, and K. Honma et al. Progression from near-normal to end-stage lungs in chronic interstitial pneumonia related to silica exposure: long-term CT observations AJR Am J Roentgenol 191 4 2008 1040 1045
12. H.F. Boehm, C. Fink, U. Attenberger, C. Becker, J. Behr, and M. Reiser Automated classification of normal and pathologic pulmonary tissue by topological texture features extracted from multi-detector CT in 3D Eur Radiol 18 12 2008 2745 2755
13. V.A. Zavaletta, B.J. Bartholmai, and R.A. Robb High resolution multidetector CT-aided tissue analysis and quantification of lung fibrosis Acad Radiol 14 7 2007 772 787
14. J. Wang, F. Li, and Q. Li Automated segmentation of lungs with severe interstitial lung disease in CT Med Phys 36 10 2009 4592 4599
15. A. Asakura, T. Gotoh, T. Iwasawa, K. Saito, and H. Kasaka Classification system of the CT images with nonspecific interstitial pneumonia J Inst Image Electron Eng Jpn 33 2 2004 180 188
16. H.U. Kauczor, K. Heitmann, C.P. Heussel, D. Marwede, T. Uthmann, and M. Thelen Automatic detection and quantification of ground-glass opacities on high-resolution CT using multiple neural networks: comparison with a density mask AJR Am J Roentgenol 175 5 2000 1329 1334
17. T. Iwasawa, A. Asakura, and F. Sakai et al. Assessment of prognosis of patients with idiopathic pulmonary fibrosis by computer-aided analysis of CT images J Thorac Imaging 24 3 2009 216 222
18. T. Iwasawa, T. Ogura, and H. Takahashi et al. Pneumothorax and idiopathic pulmonary fibrosis Jpn J Radiol 28 9 2010 672 679
19. N.L. Muller, R.R. Miller, W.R. Webb, K.G. Evans, and D.N. Ostrow Fibrosing alveolitis: CT-pathologic correlation Radiology 160 3 1986 585 588
20. K. Nishimura, M. Kitaichi, T. Izumi, S. Nagai, M. Kanaoka, and H. Itoh Usual interstitial pneumonia: histologic correlation with high-resolution CT Radiology 182 2 1992 337 342